A revolutionary AI program has uncovered a fresh category of antibiotics capable of eliminating bacteria that are resistant to drugs. Researchers successfully employed graph neural networks to forecast the toxicity of more than 12 million compounds, a task that is not feasible to conduct in a wet lab.
The AI has effectively detected substances that can eliminate drug-resistant strains, resulting in the development of a fresh type of antibiotics. Mouse experiments have revealed positive outcomes for the new antibiotics, effectively combating infections caused by these resilient bacteria.
This progress signifies a major breakthrough in AI applications and the development of antibiotics. By utilizing AI in drug discovery, scientists are pushing the boundaries in combating complex medical threats.
